23 Validation of PD-L1 dynamic expression on extracellular vesicles as a predictor of response to immune-checkpoint inhibitors and survival in non-small cell lung cancer patients
Main Authors: | Alessandro Russo, Christian Rolfo, Andrés Cardona, Aung Naing, Rivka Colen, Christine Peterson, Diego de Miguel Perez, Muthukumar Gunasekaran, Vincenzo Adamo, Oscar Arrieta, Feliciano Barrón, Luis Lara-Mejía, Philip Mack, Fred Hirsch |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
31 Dynamic change of PD-L1 expression on extracellular vesicles predicts response to immune-checkpoint inhibitors in non-small cell lung cancer patients
by: Alessandro Russo, et al.
Published: (2020-11-01) -
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
by: Diego de Miguel-Perez, et al.
Published: (2022-06-01) -
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC
by: Diego de Miguel‑Perez, et al.
Published: (2024-03-01) -
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer
by: Diego de Miguel-Perez, et al.
Published: (2023-11-01) -
Atorvastatin Enhances the Efficacy of Immune Checkpoint Therapy and Suppresses the Cellular and Extracellular Vesicle PD-L1
by: Eun-Ji Choe, et al.
Published: (2022-08-01)